Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma.
Amod A SarnaikOmid HamidNikhil I KhushalaniKarl D LewisTheresa MedinaHarriet M KlugerSajeve S ThomasEvidio Domingo-MusibayAnna C PavlickEric D WhitmanSalvador Martin-AlgarraPhilippa CorrieBrendan D CurtiJudit OláhJose LutzkyJeffrey S WeberJames M G LarkinWen ShiToshimi TakamuraMadan JagasiaHarry QinXiao WuCecile ChartierFriedrich Graf FinckensteinMaria FardisJoanne M JeterJason A ChesneyPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Lifileucel demonstrated durable responses and addresses a major unmet need in patients with metastatic melanoma with limited treatment options after approved therapy, including the primary refractory to anti-PD-1 or PD-L1 therapy subset.